CA Stock MarketDetailed Quotes
NAV Navco Pharmaceuticals Inc
- 0.020
- +0.005+33.33%
15min DelayTrading Nov 29 09:30 ET
1.14MMarket Cap-1000P/E (TTM)
0.020High0.020Low2.00KVolume0.020Open0.015Pre Close40.00Turnover0.11552wk High0.01%Turnover Ratio57.07MShares0.01552wk Low-0.02EPS TTM760.64KFloat Cap0.450Historical HighLossP/E (Static)38.03MShs Float0.015Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Navco Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q1)Sep 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | (Q2)Dec 31, 2021 | (Q1)Sep 30, 2021 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 77.94%-259 | -154.32%-21.44K | 94.38%-4.54K | 0.00%-258 | 99.07%-407 | 11.40%-1.17K | 61.50%-8.43K | 98.10%-258 | -67.57%-80.71K | -516.21%-43.9K |
| Net income from continuing operations | 212.92%8.31K | 76.54%-5.86K | -527.86%-465.13K | 85.37%-2.05K | -48.88%-47.38K | 57.52%-7.36K | -37.12%-24.97K | -107.59%-13.98K | -49.47%-74.08K | -121.68%-31.83K |
| Depreciation and amortization | ---- | ---- | --43.81K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non cashItems | 15.38%-1.35K | 15.90%-1.35K | 373.70%14.94K | -6.20%-1.68K | -6.17%-1.64K | -6.20%-1.59K | -6.15%-1.6K | -73.82%-1.58K | ---5.46K | ---1.54K |
| Change In working capital | -192.82%-7.22K | -178.44%-14.23K | 34,503.60%401.83K | -77.35%3.47K | 561.44%48.61K | -55.55%7.77K | 933.30%18.14K | 357.25%15.3K | -183.55%-1.17K | -245.66%-10.53K |
| -Change in inventory | ---- | ---- | --6.01K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | -192.82%-7.22K | -178.44%-14.23K | 36,180.31%421.42K | -77.35%3.47K | 561.44%48.61K | -46.60%7.77K | 2,296.43%18.14K | 357.25%15.3K | -94.02%-1.17K | -245.66%-10.53K |
| -Change in other working capital | ---- | ---- | ---25.59K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 77.94%-259 | -154.32%-21.44K | 94.38%-4.54K | 0.00%-258 | 99.07%-407 | 11.40%-1.17K | 61.50%-8.43K | 98.10%-258 | -67.57%-80.71K | -516.21%-43.9K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | |||||||||
| Net PPE purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 102.26%2K | 20K | 0 | 0 | 0 | 0 | -449.26%-88.5K | 0 |
| Net issuance payments of debt | --0 | --0 | 102.03%2K | --20K | --0 | --0 | --0 | --0 | -488.73%-98.5K | --0 |
| Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | 102.26%2K | --20K | --0 | --0 | --0 | --0 | -449.26%-88.5K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -96.92%104 | 82.41%21.54K | -97.75%4.07K | -85.09%1.8K | -93.96%3.38K | -94.10%3.38K | -82.93%11.81K | -93.34%12.07K | -11.18%181.28K | -70.29%55.97K |
| Current changes in cash | ---259 | -154.32%-21.44K | 98.50%-2.54K | 7,751.94%19.74K | 96.40%-1.58K | --0 | 29.14%-8.43K | 99.77%-258 | -641.27%-169.21K | -516.21%-43.9K |
| End cash Position | -104.59%-155 | -96.92%104 | -87.28%1.54K | 82.41%21.54K | -85.09%1.8K | -93.96%3.38K | -94.10%3.38K | -82.93%11.81K | -93.34%12.07K | -93.34%12.07K |
| Free cash from | 77.94%-259 | -154.32%-21.44K | 94.38%-4.54K | 0.00%-258 | 99.07%-407 | 11.40%-1.17K | 61.50%-8.43K | 98.10%-258 | -67.57%-80.71K | -516.21%-43.9K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data